What Is N-Methylation in Peptides? How a Backbone Methyl Group Changes a Peptide

Published October 2026 · Patriot Labs Research Team · ~21 min read

The short answer

N-methylation is the replacement of the hydrogen on a peptide’s backbone amide nitrogen (N–H) with a methyl group (N–CH₃), turning an ordinary secondary amide into a tertiary one. It happens on the backbone itself rather than on a side chain, it adds a fixed 14 daltons of mass per methyl group, and it is carried by an N-methyl amino acid — the simplest being sarcosine, or N-methylglycine.

The substitution looks trivial on paper — one hydrogen becomes three — but it changes three things at once. It removes a hydrogen-bond donor while leaving the carbonyl acceptor in place; it plants bulk on the nitrogen that stiffens and reshapes the chain, bringing the normally rare cis form of the amide bond within easy reach; and it strips away a feature that many proteolytic enzymes depend on to recognise and cut the backbone.^[1][2] The net result is a peptide that folds differently and survives longer.

That combination is why N-methylation is one of the most heavily used backbone modifications in peptide medicinal chemistry. Nature got there first: cyclosporine, a cyclic fungal peptide with seven of its eleven backbone amides methylated, is famously stable and orally absorbed, and it is the molecule that showed chemists what deliberate N-methylation could do.^[3][6] The rest of this guide takes the change apart piece by piece — the bond, the deleted hydrogen, the shape, the stability, the permeability, the chemistry of making it — and ends with what the topic does and does not say about any individual research vial.

The methyl group and the bond it changes

N-methylation acts on the peptide bond itself. A normal peptide bond is a secondary amide: a carbonyl carbon joined to a nitrogen that still carries one hydrogen (C(=O)–N–H). N-methylation replaces that single hydrogen with a methyl group, producing a tertiary amide (C(=O)–N–CH₃). Everything else about the residue — its side chain, its alpha carbon, its stereochemistry — is untouched; the edit is confined to the backbone nitrogen.^[1][2]

Because only an H is swapped for a CH₃, the mass bookkeeping is simple and exact: the residue gains one carbon and two hydrogens, a net addition of a methylene unit, so every N-methylation adds a nominal 14 daltons. The change is also electrically quiet — unlike phosphorylation, which plants a double negative charge, N-methylation adds no charge at all. What it adds is a small lipophilic group and, more importantly, a change in what the nitrogen can and cannot do.

The residue that carries the methyl group is an N-methyl amino acid. Build one into a chain and it forms the tertiary amide at that position. The simplest of them is sarcosine — N-methylglycine — a naturally occurring amino acid that is literally glycine with a methyl on its nitrogen.^[12] N-methyl versions of the standard residues, such as N-methyl-leucine or N-methyl-phenylalanine, are made as protected building blocks for exactly this purpose.^[7]

The missing hydrogen: what N-methylation deletes

The single most consequential thing N-methylation does is subtract a hydrogen-bond donor. A backbone N–H can donate a hydrogen bond; an N–CH₃ cannot. The carbonyl oxygen next door is untouched and still accepts hydrogen bonds, so the modification is strictly one-sided: it removes a donor and keeps the acceptor.^[2][6]

That one subtraction ripples outward. A backbone N–H is a polar group that, in water, is wrapped in a shell of hydrogen-bonded water molecules; shedding that shell is part of the energetic price a peptide pays to enter a lipid membrane. Replace the N–H with a methyl and that particular cost disappears, raising the local lipophilicity.^[14] Removing backbone donors also frees the peptide to satisfy its remaining polar groups internally — folding so that the carbonyls that can still accept bonds do so within the molecule rather than reaching out to solvent. Both effects feed directly into the permeability story later in this guide. The table below sets the two amides side by side.

Conformation: cis bonds and locked shapes

N-methylation reshapes a peptide because it rewrites the rules of the amide bond it sits on. In an ordinary secondary amide the trans arrangement is strongly preferred, by something like a thousand to one, because the two bulky groups sit on opposite sides. Put a methyl on the nitrogen and that preference collapses: now there is a bulky group on each side whichever way the bond turns, so the energy gap between cis and trans shrinks and the cis form becomes genuinely populated.^[2][6]

A cis amide bond is a sharp kink in the chain, and kinks are how peptides make turns. By making cis bonds accessible, N-methylation gives a peptide ready access to tight turn structures and, in a ring, helps it settle into one or two well-defined shapes rather than a floppy ensemble. The added steric bulk reinforces this, narrowing the backbone’s conformational freedom around the methylated nitrogen.^[2]

Cyclosporine is again the textbook case. In an apolar environment it folds into a compact “closed” shape held together by a handful of internal hydrogen bonds, with one of its N-methylated amides sitting in the cis form; in water it opens up. The ability to switch between a membrane-friendly closed state and a water-friendly open one is tied directly to its backbone N-methyls.^[6] The lesson generalises: because conformation controls both how a peptide is recognised and how it moves through the body, controlling conformation through N-methylation is controlling behaviour.

Why N-methylated peptides resist proteases

Peptides are fragile in biological settings largely because proteases — enzymes that cut peptide bonds — are everywhere, and an unmodified peptide is often degraded within minutes.^[14] N-methylation is one of the most reliable ways to slow that down. The published literature repeatedly reports that placing a methyl on the backbone nitrogen increases a peptide’s resistance to enzymatic degradation.^[1][2][3]

The reason is mechanical. A protease has to grip its target along the backbone and position the scissile bond precisely in its active site, and that grip typically involves the backbone amide hydrogens as hydrogen-bond contacts. Methylating the nitrogen removes one of those contacts and jams a methyl group into the space the enzyme needs, so the bond no longer fits the active site cleanly. The practical consequence, documented across many studies, is a longer-lived molecule — one of the properties that makes N-methylation attractive when a peptide’s native form is cleaved too fast to study conveniently.^[2][6]

Two caveats keep this honest. First, the effect is local and position-dependent: methylating the residues flanking a protease’s preferred cut site helps most, and a single methyl elsewhere may do little. Second, stability against enzymes is a property of a defined molecule, not a universal guarantee — it is measured, not assumed. This is the same logic that governs ordinary chemical breakdown, covered in how peptides degrade.

Permeability and the oral-bioavailability question

The property that made N-methylation famous is membrane permeability. Peptides are generally poor at crossing cell membranes and are therefore hard to deliver by mouth; a large part of the problem is the row of polar backbone N–H donors that must be stripped of their water shell to enter a lipid bilayer. N-methylation removes those donors one at a time, and in the right positions it can turn an impermeable peptide into a permeable one.^[6][14]

The research record on this is specific and quantitative. Working from the cyclosporine precedent, Kessler, Hoffman and colleagues showed that multiply N-methylating a cyclic somatostatin analogue produced a derivative with greatly improved metabolic stability and intestinal permeability, reaching roughly 10 percent oral bioavailability — a landmark for a cyclic peptide.^[3][4] Later work using on-resin N-methylation to scan a cyclic hexapeptide scaffold produced a triple-N-methylated compound of 755 daltons with about 28 percent oral bioavailability in rats.^[5] Systematic studies of N-methyl scanning libraries have found that a minority of methylation patterns deliver high passive permeability — in one cyclic-hexapeptide library, some analogues matched a passive-diffusion reference marker.^[6]

The crucial qualifier runs through all of this work: the effect is intensely position-dependent. In one well-studied cyclic peptide, methylating one residue dramatically raised permeability while methylating a neighbour reduced it.^[6] There is no blanket rule that “more methyls means more permeable”; which nitrogens are methylated matters far more than how many, which is exactly why chemists scan positions systematically rather than methylating everything.^[2][6]

N-methylation in nature

N-methylation is not only a chemist’s trick; nature uses it too, and the natural examples are what pointed the way. The simplest is sarcosine, N-methylglycine, a normal metabolite of choline and glycine found in muscle and other tissues.^[12] Beyond that lie whole families of N-methylated natural products built by microbes and fungi.

The most important of these is cyclosporine. It is made not by ribosomes but by a large enzyme assembly line — a nonribosomal peptide synthetase called cyclosporin synthetase — which stitches eleven residues into a ring and, as part of the process, transfers methyl groups onto seven of the backbone nitrogens using S-adenosyl methionine as the methyl donor.^[11] The result is the heavily N-methylated, highly stable, orally absorbed molecule that has anchored this field for decades.

Backbone N-methylation also appears in ribosomal pathways. A class of fungal enzymes known as borosin methyltransferases installs backbone N-methyl groups on ribosomally made peptides — the fungal peptide omphalotin A is multiply backbone-N-methylated by one such enzyme — and SAM-dependent methyltransferases decorate many other natural peptides on nitrogen atoms.^[13] The through-line is consistent: when evolution wanted a peptide that could hold a shape and survive, N-methylation was one of the tools it reached for.

How N-methyl peptides are made

N-methyl peptides are made deliberately, and the chemistry is a well-developed branch of solid-phase peptide synthesis. There are two broad strategies, differing in when the methyl group is introduced.^[2][7][10]

The building-block approach installs the methyl before assembly. A protected N-methyl amino acid — for instance an Fmoc-protected N-methyl residue — is prepared in advance and coupled into the growing chain at the chosen position like any other residue. A long review by Aurelio and colleagues catalogues the many ways these N-methyl amino acids are synthesised, from alkylation of protected amines to reductive methylation and oxazolidinone ring-opening.^[7] The approach is clean and predictable and is the usual choice when one or two positions need methylating.

The on-resin approach methylates a chosen backbone nitrogen after the chain is already built on the resin. The classic route, developed from Fukuyama’s nitrobenzenesulfonyl (“nosyl”) chemistry and adapted to peptides by Miller and Scanlan, protects the free amine as a nosyl sulfonamide, methylates it under Mitsunobu conditions (or with another methylating agent), and then removes the nosyl group — a sequence mild enough to leave the rest of the peptide intact.^[8][9] Kessler’s group streamlined the method into a practical “N-methyl scan,” and microwave-assisted protocols made the harder couplings around an N-methyl residue more reliable.^[10]

Either way, the hindered nitrogen makes life harder for the chemist. Coupling a residue onto an N-methyl amino acid, and coupling the N-methyl amino acid itself, is slower and lower-yielding because of the steric bulk; the tertiary amide is more prone to the diketopiperazine side reaction that can clip the first two residues off the resin; and the alkylation chemistry has to be managed to avoid racemising the stereocentre.^[2][7][10] These are the practical reasons an N-methyl peptide is more demanding to make — and to purify and verify — than its plain counterpart, part of the broader manufacturing picture in how peptides are made.

The +14-dalton signature and how it is checked

N-methylation leaves a clean analytical fingerprint, which is one of its conveniences. Each methyl group adds a nominal 14 daltons — the mass of a CH₂ unit, since a hydrogen is replaced by CH₃ — so a peptide carrying two N-methyls is about 28 daltons heavier than its unmethylated form, three is about 42, and so on. The shift is small, fixed and countable, and mass spectrometry reads it directly: the measured mass tells you how many methyl groups are present.

Counting the methyls is not quite the same as locating them, because 14 daltons added here looks identical in a simple mass measurement to 14 daltons added there. Tandem mass spectrometry, which breaks the chain into fragments, together with the retention behaviour on reversed-phase HPLC, is used to pin each methyl to the right residue and to confirm that the product is the intended isomer rather than a mis-methylated one.^[2] For a synthetic N-methyl peptide the practical questions are narrow — are the right number of methyls present, in the right places, and how pure is the material — and they are answered by the same HPLC-plus-mass-spectrometry pairing that an independent US laboratory uses to document identity and purity, lot by lot, on a certificate of analysis.

N-methylation in peptide drug design

Pulled together, these effects make N-methylation a core move in modern peptide medicinal chemistry, part of what the field calls working “beyond the rule of five” — the effort to give large, peptide-like molecules drug-like properties they would not normally have.^[2][5] The reasoning is straightforward: a chemist takes a peptide that binds its target but is cleaved too quickly or absorbed too poorly, scans N-methyl groups across its backbone, and looks for the pattern that keeps the activity while adding stability, shape control or permeability.

The approach has produced landmark molecules. N-methylation of a cyclic Arg-Gly-Asp (RGD) peptide was central to the design of highly active and selective integrin antagonists, the line of work behind the well-known research compound cilengitide, where a single backbone methyl sharpened both potency and selectivity.^[15] The multiply N-methylated somatostatin analogues discussed above remain a textbook demonstration that oral activity can be engineered into a cyclic peptide.^[3][4] And a steady stream of reviews continues to treat N-methylation as a first-line tactic for modulating the biological behaviour of peptides and peptidomimetics.^[2]

N-methylation next to the other modifications

N-methylation is one member of a toolkit of edits a peptide can carry, and it occupies a distinctive niche: it is a backbone change that is small, uncharged, and aimed squarely at hydrogen bonding, conformation and protease resistance. That sets it apart from its neighbours.

Acetylation and C-terminal amidation cap the ends of a peptide and chiefly neutralise a terminal charge, whereas N-methylation works at interior positions along the chain. Using D-amino acids also resists proteases, but by inverting a stereocentre rather than editing the nitrogen, and the two tactics are often combined. Lipidation and PEGylation extend half-life mainly by adding bulk that slows clearance and binds carrier proteins, a different mechanism from N-methylation’s local backbone shielding. And a cyclic backbone frequently partners with N-methylation — cyclisation and methylation together are the standard recipe for a conformationally defined, membrane-permeable peptide. Seen this way, N-methylation is the precision instrument of the set: a single, position-specific edit that adjusts shape and stability without adding charge or mass to speak of.

What this guide does not establish

This is a chemistry explainer, and its scope is deliberately narrow. It describes what N-methylation is and how it is studied; it does not describe the use of any peptide in a person or animal, and nothing here is medical, veterinary or dosing guidance. The permeability and bioavailability findings cited above are results reported for specific research molecules and approved drugs in the published literature — cyclosporine, somatostatin analogues, defined cyclic scaffolds — and they describe the behaviour of those molecules in laboratory and preclinical settings, not the behaviour or purpose of any product on this catalogue.

Two further cautions. First, whether a given catalogue peptide contains an N-methyl residue is a fact written into its specific sequence: an N-methyl peptide is a distinct molecule with the methyl group named in its structure, and only its own certificate of analysis speaks to what a particular lot contains. Second, the numbers quoted here — bioavailability percentages, methyl counts, cis/trans ratios — are findings from the cited studies on their own molecules, not properties that transfer automatically to any other peptide. Patriot Labs is a first-responder-owned, US-based company whose research materials are tested by an independent US laboratory using HPLC and mass spectrometry, with a certificate of analysis available on each product page; what any single vial contains is a question for that document, discussed in Understanding Peptide COA Testing.

Frequently asked questions

What is N-methylation?

N-methylation is the replacement of the hydrogen on a peptide backbone amide nitrogen (N–H) with a methyl group (N–CH3), turning a secondary amide into a tertiary amide. It happens on the backbone rather than a side chain, it adds a nominal 14 daltons of mass per methyl group, and it is carried by an N-methyl amino acid residue — the simplest of which is sarcosine, or N-methylglycine. The single change removes a hydrogen-bond donor, reshapes the local backbone, and is one of the most widely used backbone edits in peptide medicinal chemistry.

What is an N-methyl amino acid?

An N-methyl amino acid is an amino acid whose backbone nitrogen carries a methyl group in place of one hydrogen, so that when it is built into a peptide it forms a tertiary amide bond instead of the usual secondary amide. Sarcosine (N-methylglycine) is the simplest example and occurs naturally; N-methyl versions of standard residues, such as N-methyl-leucine or N-methyl-phenylalanine, are made as protected building blocks and coupled into a chain by solid-phase peptide synthesis.

How does N-methylation affect a peptide?

N-methylation changes a peptide in several linked ways. It removes one backbone hydrogen-bond donor (the amide N–H) while keeping the carbonyl acceptor, it adds steric bulk at the nitrogen, it lowers the energy difference between the cis and trans forms of the amide bond so cis bonds and turns become more accessible, and it makes the bond harder for proteolytic enzymes to recognise and cut. Collectively these effects can reshape the molecule's three-dimensional structure and its stability.

Does N-methylation make peptides more stable?

In the published literature, N-methylation is repeatedly reported to increase a peptide's resistance to enzymatic (proteolytic) degradation, because many proteases rely on the backbone N–H and on an unobstructed backbone to bind and cleave their target. Cyclosporine, a natural multiply N-methylated cyclic peptide, is the classic illustration of a highly stable, N-methyl-rich molecule. Stability is a property of each specific molecule, and the effect depends on which positions are methylated.

Why is cyclosporine N-methylated?

Cyclosporine (cyclosporin A) is a cyclic 11-residue peptide of fungal origin in which seven of the backbone amides are N-methylated. That heavy N-methylation, together with the ring, removes most of its backbone hydrogen-bond donors and lets it fold into a compact shape, which is widely credited for its unusual metabolic stability and its oral bioavailability of roughly 30 percent despite a molecular weight above 1,200 daltons. It is the molecule that inspired medicinal chemists to use multiple N-methylation deliberately.

How much mass does N-methylation add to a peptide?

Each N-methylation adds a nominal 14 daltons, the mass of a methylene (CH2) unit, because a hydrogen atom is replaced by a methyl group — a net gain of one carbon and two hydrogens. A peptide with two N-methyl groups is about 28 daltons heavier than its unmethylated counterpart, and so on. This fixed, countable mass shift is why mass spectrometry, run alongside HPLC, is used to confirm that the intended number of methyl groups is present.

How are N-methylated peptides made?

There are two main routes. The building-block approach couples a ready-made, protected N-methyl amino acid (for example an Fmoc-protected N-methyl residue) into the chain at the chosen position during solid-phase peptide synthesis. The on-resin approach builds the peptide normally, then methylates a selected backbone nitrogen while the chain is still on the resin — classically by protecting the amine as a nosyl (nitrobenzenesulfonyl) group, methylating under Mitsunobu conditions, and removing the nosyl group. Both must manage slower couplings and side reactions around the hindered N-methyl nitrogen.

Is sarcosine an N-methyl amino acid?

Yes. Sarcosine is N-methylglycine — glycine with a methyl group on its nitrogen — and is the simplest N-methyl amino acid. It occurs naturally in muscle and other tissues as an intermediate in choline and glycine metabolism, and it is also used as a building block in peptide chemistry, where it introduces a tertiary amide and the conformational behaviour that comes with it.

References

1. N-methylation (chemistry of N-methyl amino acids and peptides). General backbone-modification overview. Patriot Labs companion guides on the peptide bond and amino acids.
2. Chatterjee, J., Rechenmacher, F., & Kessler, H. (2013). N-Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions. Angewandte Chemie International Edition, 52(1), 254–269. doi:10.1002/anie.201205674
3. Chatterjee, J., Gilon, C., Hoffman, A., & Kessler, H. (2008). N-Methylation of Peptides: A New Perspective in Medicinal Chemistry. Accounts of Chemical Research, 41(10), 1331–1342. doi:10.1021/ar8000603
4. Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., & Kessler, H. (2008). Improving Oral Bioavailability of Peptides by Multiple N-Methylation: Somatostatin Analogues. Angewandte Chemie International Edition, 47(14), 2595–2599. doi:10.1002/anie.200705797
5. White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., Bauman, J. N., Zhang, Y., Liras, S., Price, D. A., Mathiowetz, A. M., Jacobson, M. P., & Lokey, R. S. (2011). On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nature Chemical Biology, 7(11), 810–817. doi:10.1038/nchembio.664
6. Li, Y., Li, W., & Xu, Z. (2021). Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool. Marine Drugs, 19(6), 311. doi:10.3390/md19060311
7. Aurelio, L., Brownlee, R. T. C., & Hughes, A. B. (2004). Synthetic Preparation of N-Methyl-α-amino Acids. Chemical Reviews, 104(12), 5823–5846. doi:10.1021/cr030024z
8. Miller, S. C., & Scanlan, T. S. (1997). Site-Selective N-Methylation of Peptides on Solid Support. Journal of the American Chemical Society, 119(9), 2301–2302. doi:10.1021/ja9635443
9. Fukuyama, T., Jow, C.-K., & Cheung, M. (1995). 2- and 4-Nitrobenzenesulfonamides: Exceptionally versatile means for preparation of secondary amines and protection of amines. Tetrahedron Letters, 36(36), 6373–6374. doi:10.1016/0040-4039(95)01316-A
10. Roodbeen, R., & Jensen, K. J. (2013). Synthesis of N-Methylated Peptides: On-Resin Methylation and Microwave-Assisted Couplings. In Peptide Synthesis and Applications (Methods in Molecular Biology), pp. 141–149. Humana Press. doi:10.1007/978-1-62703-544-6_10
11. Ciclosporin (cyclosporin A): cyclic 11-residue fungal peptide, nonribosomal origin, N-methylation via S-adenosyl methionine, oral bioavailability. Wikipedia. https://en.wikipedia.org/wiki/Ciclosporin
12. Sarcosine (N-methylglycine): the N-methyl derivative of glycine. Wikipedia. https://en.wikipedia.org/wiki/Sarcosine
13. Schröder, M.-P., Pfeiffer, I. P.-M., & Mordhorst, S. (2024). Methyltransferases from RiPP pathways: shaping the landscape of natural product chemistry (backbone N-methylation; borosin enzymes; omphalotin A). Beilstein Journal of Organic Chemistry, 20, 1652–1670. doi:10.3762/bjoc.20.147
14. Bioavailability of peptides (N-methylation, hydrogen bonding, protease stability and membrane permeability). Bachem Knowledge Center. https://www.bachem.com/knowledge-center/bioavailability-of-peptides/
15. Dechantsreiter, M. A., Planker, E., Mathä, B., Lohof, E., Hölzemann, G., Jonczyk, A., Goodman, S. L., & Kessler, H. (1999). N-Methylated Cyclic RGD Peptides as Highly Active and Selective α_Vβ₃ Integrin Antagonists. Journal of Medicinal Chemistry, 42(16), 3033–3040. doi:10.1021/jm970832g

For more on the chemistry this guide touches, see What Is Acetylation? and What Is Amidation? for two terminal edits, What Are D-Amino Acids in Peptides? for the other classic protease-resistance tactic, Peptide Half-Life Extension for the wider toolkit of making peptides last, and What Is Solid-Phase Peptide Synthesis? for how an N-methyl peptide is actually built.

All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption. This guide is educational and explains N-methylation as a topic in peptide and protein chemistry; it is not medical advice, does not describe how to use any product, and makes no therapeutic claim.